Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Graft Failure”

42 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 42 results

Not applicableStudy completedNCT07048730
What this trial is testing

Gynecological Impact of Allogeneic Hematopoietic Stem Cell Transplantation in Adults

Who this might be right for
Acute Leukemia
University Hospital, Bordeaux 51
Early research (Phase 1)Study completedNCT01967953
What this trial is testing

Ex-Vivo Lung Perfusion to Increase the Number of Organs for Transplantation

Who this might be right for
Disorder Related to Lung TransplantationBrain DeathGraft Failure+1 more
Policlinico Hospital 7
Large-scale testing (Phase 3)Study completedNCT00755040
What this trial is testing

Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder

Who this might be right for
Chronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more
Vanderbilt-Ingram Cancer Center 164
Not applicableUnknownNCT04105803
What this trial is testing

Cardiac Mitochondrial Function After Heart Transplantation

Who this might be right for
Cardiac Allograft VasculopathyAcute Cellular Graft RejectionPrimary Graft Failure+1 more
University of Aarhus 64
Testing effectiveness (Phase 2)Ended earlyNCT01856582
What this trial is testing

CD34+ Stem Cell Infusion to Augment Graft Function

Who this might be right for
Waning Donor ChimerismWaning Immune FunctionPrimary Immunodeficiency Disease(s)+1 more
Children's Hospital Medical Center, Cincinnati 23
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableUnknownNCT06950931
What this trial is testing

Posttranslationally Modified Fetuin-A in Urine as a Marker for Renal Dysfunction (Patients With Chronic Kidney Disease - With or Without Kidney Transplantation).

Who this might be right for
Transplant Recipient (Kidney)Primary Kidney Transplantation
University Hospital, Martin 86
Not applicableStudy completedNCT04446546
What this trial is testing

Results of Cold Stored Allografts in Vascular Access

Who this might be right for
End Stage Renal Failure on DialysisHemodialysis Access Failure
Central Hospital, Nancy, France 120
Large-scale testing (Phase 3)Study completedNCT01680861
What this trial is testing

Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium

Who this might be right for
Transplant; Failure, Kidney
Gaetano Ciancio 32
Testing effectiveness (Phase 2)Ended earlyNCT00720629
What this trial is testing

Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Graft Versus Host Disease
H. Lee Moffitt Cancer Center and Research Institute 8
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660783
What this trial is testing

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureHemoglobinopathiesPrimary Immune Deficiency (PID)+4 more
Fred Hutchinson Cancer Center 40
Not applicableLooking for participantsNCT02161783
What this trial is testing

Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation

Who this might be right for
Primary Graft FailureSecondary Graft Failure
Masonic Cancer Center, University of Minnesota 50
Not applicableUnknownNCT04812054
What this trial is testing

Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death

Who this might be right for
Liver CirrhosisLiver TumorLiver Transplant Failure and Rejection
Medical University of Warsaw 104
Early research (Phase 1)UnknownNCT03836690
What this trial is testing

Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation

Who this might be right for
LymphomaLeukemiaMyeloma+4 more
University College, London 18
Testing effectiveness (Phase 2)UnknownNCT03019809
What this trial is testing

A Trial of Plerixafor/G-CSF as Additional Agents for Conditioning Before TCR Alpha/Beta Depleted HSCT in WAS Patients

Who this might be right for
Wiskott-Aldrich SyndromeHematopoietic Stem Cell TransplantationGraft Failure
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 30
Not applicableEnded earlyNCT00290628
What this trial is testing

Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
Chronic Myeloproliferative DisordersDiamond-blackfan AnemiaFanconi Anemia+6 more
Masonic Cancer Center, University of Minnesota 43
Early research (Phase 1)Ended earlyNCT02231710
What this trial is testing

Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases

Who this might be right for
Primary Immune Deficiency DisordersHemophagocytic LymphohistiocytosisInherited Bone Marrow Failure Syndrome+2 more
Bellicum Pharmaceuticals 1
Testing effectiveness (Phase 2)Ended earlyNCT01875874
What this trial is testing

Safety and Efficacy of the ELAD System (ELAD) to Treat Acute Liver Failure (ALF)

Who this might be right for
Acute Liver FailureFulminant Hepatic FailurePrimary Graft Non-Function+1 more
Vital Therapies, Inc. 8
Next Page